The aim of this study was to analyse and compare the effects of GH and IGF-1 supplementation in liver, adipokines and muscular tissue in an NAFLD experimental model that resembles features of early NAFLD stages including obesity and insulin resistance. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.